Expect a bumpy ride this week when FDA advisers consider Covid-19 booster shots
CNN
Last December, when FDA advisers met to consider whether the agency should authorize Pfizer's Covid-19 vaccine, it was generally understood that the answer would be yes.
Nine months later, those advisers are meeting to discuss booster shots, and the situation is very different.
It won't be a slam dunk.
More Related News